NEW YORK, Jan 8 – Structural genomics company Syrrx expects to close a $54 million Series C round of venture funding Tuesday, the company announced Monday.

This financing effort follows an October 3 announcement that Syrrx had raised $20 million in Series B venture funding. The San Diego-based company has raised $79 million to date

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.